PRLD
Prelude Therapeutics Incorporated
NASDAQ · Healthcare · Biotechnology · US
$5.46
+4.00%Leverage
- Debt / equity
- 0.13x
- Net debt / equity
- -0.06x
- Debt / assets
- 0.09x
- Debt / EBITDA
- -0.30x
- Net debt / EBITDA
- 0.15x
Liquidity & coverage
- Current ratio
- 4.07x
- Quick ratio
- 4.07x
- Cash ratio
- 3.99x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $116.9M
Cash & dividend
- FCF / debt
- -1.88x
- Cash flow / debt
- -1.88x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026